Symbols / NBTX $32.76 +5.54% Nanobiotix S.A.
NBTX Chart
About
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 1.59B |
| Enterprise Value | 1.45B | Income | -23.96M | Sales | 32.59M |
| Book/sh | -1.65 | Cash/sh | 1.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | 206.54 | PEG | — |
| P/S | 48.72 | P/B | -19.79 | P/C | — |
| EV/EBITDA | -155.57 | EV/Sales | 44.50 | Quick Ratio | 0.95 |
| Current Ratio | 1.09 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.58 | EPS next Y | 0.16 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-31 | ROA | -10.00% |
| ROE | — | ROIC | — | Gross Margin | 100.00% |
| Oper. Margin | -195.35% | Profit Margin | -73.52% | Shs Outstand | 48.47M |
| Shs Float | 31.08M | Short Float | 0.04% | Short Ratio | 0.28 |
| Short Interest | — | 52W High | 41.89 | 52W Low | 2.99 |
| Beta | — | Avg Volume | 46.33K | Volume | 22.34K |
| Target Price | $32.73 | Recom | Strong_buy | Prev Close | $31.04 |
| Price | $32.76 | Change | 5.54% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-02 | main | Guggenheim | Buy → Buy | $36 |
| 2026-02-06 | main | Guggenheim | Buy → Buy | $26 |
| 2025-04-04 | main | Guggenheim | Buy → Buy | $8 |
| 2024-08-28 | init | Guggenheim | — → Buy | $12 |
| 2023-12-08 | init | Leerink Partners | — → Outperform | $11 |
| 2021-01-06 | init | Evercore ISI Group | — → Outperform | — |
- Responsive Playbooks and the NBTX Inflection - Stock Traders Daily Mon, 06 Apr 2026 14
- Nanobiotix S.A. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:NBTX) 2026-04-03 - Seeking Alpha Fri, 03 Apr 2026 23
- Guggenheim Maintains Buy Rating on NBTX, Raises Price Target to $36.00 | NBTX Stock News - GuruFocus hu, 02 Apr 2026 15
- Up to $71M gives Nanobiotix runway for 2026 cancer data - Stock Titan ue, 31 Mar 2026 20
- Nanobiotix (NASDAQ:NBTX) Shares Gap Down - Time to Sell? - MarketBeat hu, 02 Apr 2026 15
- symbol__ Stock Quote Price and Forecast - CNN Wed, 07 May 2025 07
- Nanobiotix (NBTX) Surges 9.88%: What's Fueling This Biotech Breakout? - Bitget Wed, 01 Apr 2026 17
- Biotech Stock Nanobiotix (NBTX) Is Up 660% This Year -- Here's Why the Rally Could Continue - The Motley Fool Mon, 24 Nov 2025 08
- Nanobiotix sets April 1 webcast after releasing 2025 results - Stock Titan hu, 26 Mar 2026 07
- Nanobiotix stock gains after J&J buyout rumors (NBTX:NASDAQ) - Seeking Alpha Wed, 25 Mar 2026 07
- Guggenheim Increases Nanobiotix (NASDAQ:NBTX) Price Target to $36.00 - MarketBeat hu, 02 Apr 2026 14
- Understanding the Setup: (NBTX) and Scalable Risk - Stock Traders Daily hu, 26 Mar 2026 13
- Takeover speculation hits Nanobiotix; company says no process exists - Stock Titan Wed, 25 Mar 2026 07
- Nanobiotix S.A.: Behind The Recent Momentum (NASDAQ:NBTX) - Seeking Alpha hu, 23 Oct 2025 07
- Nanobiotix (NASDAQ: NBTX) trims 2025 loss and secures cash runway into 2028 - Stock Titan ue, 31 Mar 2026 20
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
29.64
+355.32%
|
-11.61
-138.63%
|
30.06
|
0.00
|
| Operating Revenue |
|
22.68
+229.36%
|
-17.53
-158.94%
|
29.75
|
0.00
|
| Operating Expense |
|
40.46
-28.74%
|
56.78
-0.10%
|
56.84
+21.70%
|
46.70
|
| Research And Development |
|
23.11
-42.98%
|
40.54
+5.59%
|
38.40
+17.65%
|
32.64
|
| Selling General And Administration |
|
20.22
+0.81%
|
20.06
-7.40%
|
21.66
+23.92%
|
17.48
|
| General And Administrative Expense |
|
20.22
+0.81%
|
20.06
-7.40%
|
21.66
+23.92%
|
17.48
|
| Salaries And Wages |
|
12.23
+2.00%
|
11.99
+1.82%
|
11.77
+21.51%
|
9.69
|
| Other Gand A |
|
8.00
-0.95%
|
8.07
-18.36%
|
9.89
+26.91%
|
7.79
|
| Other Operating Expenses |
|
-0.40
+51.73%
|
-0.84
-286.83%
|
0.45
+30.61%
|
0.34
|
| Total Expenses |
|
40.46
-28.74%
|
56.78
-0.10%
|
56.84
+21.70%
|
46.70
|
| Operating Income |
|
-10.82
+84.18%
|
-68.39
-155.40%
|
-26.78
+42.66%
|
-46.70
|
| Total Operating Income As Reported |
|
2.09
+103.06%
|
-68.39
-155.39%
|
-26.78
+42.66%
|
-46.70
|
| EBITDA |
|
-12.07
+79.31%
|
-58.33
-93.87%
|
-30.09
+39.46%
|
-49.70
|
| Normalized EBITDA |
|
-8.83
+85.59%
|
-61.31
-158.01%
|
-23.76
+54.13%
|
-51.80
|
| Reconciled Depreciation |
|
1.50
-7.77%
|
1.62
+7.14%
|
1.51
+0.87%
|
1.50
|
| EBIT |
|
-13.56
+77.37%
|
-59.95
-89.71%
|
-31.60
+38.28%
|
-51.20
|
| Total Unusual Items |
|
-3.23
-208.34%
|
2.98
+147.22%
|
-6.32
-400.19%
|
2.11
|
| Total Unusual Items Excluding Goodwill |
|
-3.23
-208.34%
|
2.98
+147.22%
|
-6.32
-400.19%
|
2.11
|
| Special Income Charges |
|
—
|
—
|
0.00
|
0.00
|
| Net Income |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Pretax Income |
|
-23.96
+64.78%
|
-68.03
-71.88%
|
-39.58
+30.60%
|
-57.03
|
| Net Non Operating Interest Income Expense |
|
-9.91
-277.37%
|
-2.62
+59.49%
|
-6.48
+47.89%
|
-12.44
|
| Interest Expense Non Operating |
|
10.39
+28.56%
|
8.09
+1.30%
|
7.98
+36.75%
|
5.84
|
| Net Interest Income |
|
-9.91
-277.37%
|
-2.62
+59.49%
|
-6.48
+47.89%
|
-12.44
|
| Interest Expense |
|
10.39
+28.56%
|
8.09
+1.30%
|
7.98
+36.75%
|
5.84
|
| Interest Income Non Operating |
|
0.98
-62.53%
|
2.63
+116.02%
|
1.22
+375.39%
|
0.26
|
| Interest Income |
|
0.98
-62.53%
|
2.63
+116.02%
|
1.22
+375.39%
|
0.26
|
| Other Income Expense |
|
-3.23
-208.34%
|
2.98
+147.22%
|
-6.32
-400.19%
|
2.11
|
| Gain On Sale Of Security |
|
-3.23
-208.34%
|
2.98
+147.22%
|
-6.32
-400.19%
|
2.11
|
| Tax Provision |
|
0.00
-97.03%
|
0.10
-15.83%
|
0.12
+1100.00%
|
0.01
|
| Tax Rate For Calcs |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.81
-208.34%
|
0.75
+147.22%
|
-1.58
-400.19%
|
0.53
|
| Net Income Including Noncontrolling Interests |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Net Income From Continuing Operation Net Minority Interest |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Net Income From Continuing And Discontinued Operation |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Net Income Continuous Operations |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Normalized Income |
|
-21.54
+69.40%
|
-70.37
-101.30%
|
-34.96
+40.36%
|
-58.62
|
| Net Income Common Stockholders |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Diluted EPS |
|
-0.50
+65.28%
|
-1.44
-33.33%
|
-1.08
+34.15%
|
-1.64
|
| Basic EPS |
|
-0.50
+65.28%
|
-1.44
-33.33%
|
-1.08
+34.15%
|
-1.64
|
| Basic Average Shares |
|
47.82
+1.17%
|
47.27
+27.99%
|
36.93
+6.17%
|
34.78
|
| Diluted Average Shares |
|
47.82
+1.17%
|
47.27
+27.99%
|
36.93
+6.17%
|
34.78
|
| Diluted NI Availto Com Stockholders |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Amortization |
|
0.00
+0.00%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Amortization Of Intangibles Income Statement |
|
0.00
+0.00%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Depreciation Amortization Depletion Income Statement |
|
0.34
+8.15%
|
0.32
+18.15%
|
0.27
-19.40%
|
0.34
|
| Depreciation And Amortization In Income Statement |
|
0.34
+8.15%
|
0.32
+18.15%
|
0.27
-19.40%
|
0.34
|
| Depreciation Income Statement |
|
0.34
+8.18%
|
0.32
+17.78%
|
0.27
-19.16%
|
0.33
|
| Other Taxes |
|
-2.82
+14.64%
|
-3.30
+16.22%
|
-3.94
+3.72%
|
-4.09
|
| Rent And Landing Fees |
|
—
|
—
|
—
|
—
|
| Rent Expense Supplemental |
|
—
|
—
|
—
|
—
|
| Total Other Finance Cost |
|
0.50
+117.51%
|
-2.83
-893.68%
|
-0.28
-104.16%
|
6.86
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
67.76
+0.51%
|
67.42
-28.20%
|
93.90
+57.10%
|
59.77
|
| Current Assets |
|
62.75
+2.09%
|
61.47
-29.62%
|
87.34
+66.81%
|
52.36
|
| Cash Cash Equivalents And Short Term Investments |
|
52.75
+6.06%
|
49.74
-33.93%
|
75.28
+81.90%
|
41.39
|
| Cash And Cash Equivalents |
|
52.75
+6.06%
|
49.74
-33.93%
|
75.28
+81.90%
|
41.39
|
| Cash Equivalents |
|
51.94
+16.91%
|
44.43
|
0.00
-100.00%
|
2.81
|
| Cash Financial |
|
0.81
-84.74%
|
5.31
-92.95%
|
75.28
+95.16%
|
38.58
|
| Receivables |
|
7.68
-10.02%
|
8.54
-10.11%
|
9.49
+18.87%
|
7.99
|
| Accounts Receivable |
|
2.14
-28.25%
|
2.98
+228.95%
|
0.91
+796.04%
|
0.10
|
| Other Receivables |
|
1.43
+31.43%
|
1.08
-68.82%
|
3.48
+26.96%
|
2.74
|
| Taxes Receivable |
|
4.12
-7.94%
|
4.47
-12.47%
|
5.11
-0.70%
|
5.15
|
| Prepaid Assets |
|
2.32
-27.45%
|
3.19
+24.80%
|
2.56
-14.12%
|
2.98
|
| Other Current Assets |
|
0.00
+300.00%
|
-0.00
-200.00%
|
0.00
+0.00%
|
0.00
|
| Total Non Current Assets |
|
5.01
-15.81%
|
5.95
-9.26%
|
6.56
-11.52%
|
7.41
|
| Net PPE |
|
4.57
-17.55%
|
5.54
-11.41%
|
6.25
-12.21%
|
7.12
|
| Gross PPE |
|
17.01
+2.71%
|
16.56
+5.39%
|
15.71
+2.69%
|
15.30
|
| Accumulated Depreciation |
|
-12.44
-12.88%
|
-11.02
-16.49%
|
-9.46
-15.66%
|
-8.18
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
9.07
+0.45%
|
9.03
+2.59%
|
8.80
+3.97%
|
8.46
|
| Machinery Furniture Equipment |
|
4.71
+1.33%
|
4.65
+5.68%
|
4.40
+0.73%
|
4.37
|
| Construction In Progress |
|
0.64
+63.94%
|
0.39
+107.98%
|
0.19
-45.35%
|
0.34
|
| Other Properties |
|
2.59
+3.81%
|
2.49
+7.13%
|
2.33
+9.45%
|
2.13
|
| Goodwill And Other Intangible Assets |
|
0.01
+42.86%
|
0.01
-12.50%
|
0.01
+700.00%
|
0.00
|
| Other Intangible Assets |
|
0.01
+42.86%
|
0.01
-12.50%
|
0.01
+700.00%
|
0.00
|
| Investments And Advances |
|
—
|
—
|
0.00
|
0.00
|
| Non Current Prepaid Assets |
|
0.41
+0.74%
|
0.41
+35.79%
|
0.30
+2.75%
|
0.29
|
| Other Non Current Assets |
|
0.03
|
—
|
—
|
—
|
| Total Liabilities Net Minority Interest |
|
152.24
+14.36%
|
133.12
+39.04%
|
95.74
+10.28%
|
86.81
|
| Current Liabilities |
|
57.51
-2.42%
|
58.94
+18.17%
|
49.87
+31.47%
|
37.94
|
| Payables And Accrued Expenses |
|
16.55
-39.98%
|
27.58
+6.63%
|
25.86
+56.97%
|
16.48
|
| Payables |
|
14.01
+16.49%
|
12.03
-17.02%
|
14.49
+30.79%
|
11.08
|
| Accounts Payable |
|
6.58
+46.74%
|
4.48
-33.02%
|
6.70
+67.42%
|
4.00
|
| Other Payable |
|
0.61
-8.78%
|
0.67
+60.00%
|
0.42
-13.93%
|
0.49
|
| Current Accrued Expenses |
|
2.54
-83.66%
|
15.55
+36.78%
|
11.37
+110.77%
|
5.39
|
| Employee Benefits |
|
0.51
+17.36%
|
0.43
+33.75%
|
0.32
+19.63%
|
0.27
|
| Total Tax Payable |
|
6.82
-0.79%
|
6.87
-6.88%
|
7.38
+11.89%
|
6.59
|
| Current Debt And Capital Lease Obligation |
|
4.31
-12.49%
|
4.92
-1.95%
|
5.02
+10.13%
|
4.56
|
| Current Debt |
|
3.10
-15.40%
|
3.66
-4.19%
|
3.82
+6.25%
|
3.60
|
| Other Current Borrowings |
|
3.10
-15.40%
|
3.66
-4.19%
|
3.82
+6.25%
|
3.60
|
| Current Capital Lease Obligation |
|
1.21
-4.04%
|
1.26
+5.17%
|
1.20
+24.64%
|
0.96
|
| Current Deferred Liabilities |
|
36.22
+99.42%
|
18.16
-0.37%
|
18.23
+9.99%
|
16.57
|
| Current Deferred Revenue |
|
36.22
+99.42%
|
18.16
-0.37%
|
18.23
+9.99%
|
16.57
|
| Other Current Liabilities |
|
0.31
-96.02%
|
7.83
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
94.74
+27.70%
|
74.19
+61.74%
|
45.87
-6.16%
|
48.88
|
| Long Term Debt And Capital Lease Obligation |
|
91.01
+97.94%
|
45.98
+0.96%
|
45.54
-6.31%
|
48.61
|
| Long Term Debt |
|
89.12
+107.21%
|
43.01
+3.24%
|
41.66
-5.40%
|
44.04
|
| Long Term Capital Lease Obligation |
|
1.89
-36.38%
|
2.97
-23.54%
|
3.88
-15.00%
|
4.57
|
| Non Current Pension And Other Postretirement Benefit Plans |
|
0.51
+17.36%
|
0.43
+33.75%
|
0.32
+19.63%
|
0.27
|
| Other Non Current Liabilities |
|
3.22
-88.41%
|
27.78
+1388700.00%
|
0.00
|
—
|
| Stockholders Equity |
|
-84.48
-28.58%
|
-65.70
-3463.07%
|
-1.84
+93.18%
|
-27.05
|
| Common Stock Equity |
|
-84.48
-28.58%
|
-65.70
-3463.07%
|
-1.84
+93.18%
|
-27.05
|
| Capital Stock |
|
1.45
+2.04%
|
1.42
+0.64%
|
1.41
+35.18%
|
1.05
|
| Common Stock |
|
1.45
+2.04%
|
1.42
+0.64%
|
1.41
+35.18%
|
1.05
|
| Share Issued |
|
48.41
+2.07%
|
47.43
+0.62%
|
47.13
+35.15%
|
34.88
|
| Ordinary Shares Number |
|
48.39
+2.07%
|
47.40
+0.62%
|
47.11
+35.17%
|
34.85
|
| Treasury Shares Number |
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
+0.00%
|
0.02
|
| Additional Paid In Capital |
|
314.40
+0.53%
|
312.74
+0.00%
|
312.74
+22.28%
|
255.76
|
| Retained Earnings |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Gains Losses Not Affecting Retained Earnings |
|
-376.14
-20.75%
|
-311.51
-12.84%
|
-276.07
-21.84%
|
-226.58
|
| Treasury Stock |
|
0.23
+0.00%
|
0.23
+0.00%
|
0.23
+0.00%
|
0.23
|
| Other Equity Adjustments |
|
-376.14
-20.75%
|
-311.51
-12.84%
|
-276.07
-21.84%
|
-226.58
|
| Total Equity Gross Minority Interest |
|
-84.48
-28.58%
|
-65.70
-3463.07%
|
-1.84
+93.18%
|
-27.05
|
| Total Capitalization |
|
4.64
+120.44%
|
-22.69
-157.00%
|
39.82
+134.28%
|
17.00
|
| Working Capital |
|
5.24
+107.15%
|
2.53
-93.24%
|
37.47
+159.78%
|
14.42
|
| Invested Capital |
|
7.74
+140.65%
|
-19.03
-143.61%
|
43.64
+111.91%
|
20.59
|
| Total Debt |
|
95.32
+87.26%
|
50.90
+0.67%
|
50.56
-4.90%
|
53.17
|
| Net Debt |
|
39.47
|
—
|
—
|
6.25
|
| Capital Lease Obligations |
|
3.10
-26.74%
|
4.23
-16.77%
|
5.08
-8.10%
|
5.53
|
| Net Tangible Assets |
|
-84.49
-28.58%
|
-65.71
-3448.06%
|
-1.85
+93.15%
|
-27.05
|
| Tangible Book Value |
|
-84.49
-28.58%
|
-65.71
-3448.06%
|
-1.85
+93.15%
|
-27.05
|
| Available For Sale Securities |
|
—
|
—
|
—
|
—
|
| Current Provisions |
|
0.12
-73.06%
|
0.44
-42.37%
|
0.76
+132.42%
|
0.33
|
| Investmentin Financial Assets |
|
—
|
—
|
0.00
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-33.42
-70.95%
|
-19.55
-56.71%
|
-12.48
+66.37%
|
-37.10
|
| Cash Flow From Continuing Operating Activities |
|
-33.42
-70.94%
|
-19.55
-56.70%
|
-12.48
+66.37%
|
-37.10
|
| Net Income From Continuing Operations |
|
-23.96
+64.83%
|
-68.13
-71.62%
|
-39.70
+30.40%
|
-57.04
|
| Depreciation Amortization Depletion |
|
1.50
-7.77%
|
1.62
+7.14%
|
1.51
+0.87%
|
1.50
|
| Depreciation And Amortization |
|
1.50
-7.77%
|
1.62
+7.14%
|
1.51
+0.87%
|
1.50
|
| Other Non Cash Items |
|
-10.83
-137.85%
|
28.61
+138.90%
|
11.97
-5.40%
|
12.66
|
| Stock Based Compensation |
|
3.54
-17.66%
|
4.30
+33.40%
|
3.22
+1.51%
|
3.17
|
| Provisionand Write Offof Assets |
|
-0.23
+14.45%
|
-0.26
-151.98%
|
0.51
+65.90%
|
0.30
|
| Deferred Tax |
|
0.00
-97.03%
|
0.10
-15.83%
|
0.12
|
0.00
|
| Deferred Income Tax |
|
0.00
-97.03%
|
0.10
-15.83%
|
0.12
|
0.00
|
| Operating Gains Losses |
|
0.15
+5200.00%
|
-0.00
+87.50%
|
-0.02
-900.00%
|
0.00
|
| Change In Working Capital |
|
-3.40
-123.81%
|
14.28
+43.98%
|
9.92
+331.49%
|
2.30
|
| Change In Receivables |
|
1.85
+421.41%
|
0.35
+132.57%
|
-1.09
+40.31%
|
-1.83
|
| Changes In Account Receivables |
|
0.84
+140.58%
|
-2.07
-156.82%
|
-0.81
-698.02%
|
-0.10
|
| Change In Payables And Accrued Expense |
|
-5.41
-376.21%
|
1.96
-77.42%
|
8.68
+198.62%
|
2.90
|
| Change In Payable |
|
-5.41
-376.21%
|
1.96
-77.42%
|
8.68
+198.62%
|
2.90
|
| Change In Other Working Capital |
|
-0.02
-100.13%
|
12.19
+656.39%
|
1.61
|
—
|
| Change In Other Current Liabilities |
|
0.17
+178.13%
|
-0.22
-130.98%
|
0.72
-40.74%
|
1.22
|
| Investing Cash Flow |
|
-0.58
+39.48%
|
-0.95
-173.64%
|
-0.35
-352.90%
|
0.14
|
| Cash Flow From Continuing Investing Activities |
|
-0.58
+39.48%
|
-0.95
-173.64%
|
-0.35
-354.74%
|
0.14
|
| Net PPE Purchase And Sale |
|
-0.54
+36.41%
|
-0.85
-157.93%
|
-0.33
-256.52%
|
-0.09
|
| Purchase Of PPE |
|
-0.54
+36.41%
|
-0.85
-157.93%
|
-0.33
-256.52%
|
-0.09
|
| Capital Expenditure |
|
-0.55
+35.61%
|
-0.85
-151.63%
|
-0.34
-262.37%
|
-0.09
|
| Net Investment Purchase And Sale |
|
-0.03
+70.09%
|
-0.11
-791.67%
|
-0.01
-105.22%
|
0.23
|
| Purchase Of Investment |
|
—
|
—
|
—
|
—
|
| Net Intangibles Purchase And Sale |
|
-0.01
-300.00%
|
-0.00
+77.78%
|
-0.01
-800.00%
|
-0.00
|
| Purchase Of Intangibles |
|
-0.01
-300.00%
|
-0.00
+77.78%
|
-0.01
-800.00%
|
-0.00
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
0.00
|
| Financing Cash Flow |
|
37.42
+828.65%
|
-5.13
-110.98%
|
46.77
+927.66%
|
-5.65
|
| Cash Flow From Continuing Financing Activities |
|
37.42
+828.67%
|
-5.13
-110.98%
|
46.77
+927.81%
|
-5.65
|
| Net Issuance Payments Of Debt |
|
38.19
+1019.11%
|
-4.16
-14.94%
|
-3.62
+23.65%
|
-4.74
|
| Issuance Of Debt |
|
42.93
|
0.00
-100.00%
|
0.15
|
0.00
|
| Repayment Of Debt |
|
-4.74
-14.18%
|
-4.16
-10.36%
|
-3.77
+20.49%
|
-4.74
|
| Long Term Debt Issuance |
|
42.93
|
0.00
-100.00%
|
0.15
|
0.00
|
| Long Term Debt Payments |
|
-4.74
-14.18%
|
-4.16
-10.36%
|
-3.77
+20.49%
|
-4.74
|
| Net Long Term Debt Issuance |
|
38.19
+1019.11%
|
-4.16
-14.94%
|
-3.62
+23.65%
|
-4.74
|
| Net Common Stock Issuance |
|
1.53
|
0.00
-100.00%
|
60.15
|
0.00
|
| Cash Dividends Paid |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
|
0.00
|
| Net Other Financing Charges |
|
-0.78
|
—
|
-2.79
-278900.00%
|
-0.00
|
| Changes In Cash |
|
3.42
+113.32%
|
-25.64
-175.53%
|
33.95
+179.66%
|
-42.62
|
| Effect Of Exchange Rate Changes |
|
-0.40
-527.66%
|
0.09
+284.31%
|
-0.05
-161.45%
|
0.08
|
| Beginning Cash Position |
|
49.74
-33.93%
|
75.28
+81.90%
|
41.39
-50.68%
|
83.92
|
| End Cash Position |
|
52.75
+6.06%
|
49.74
-33.93%
|
75.28
+81.90%
|
41.39
|
| Free Cash Flow |
|
-33.97
-66.52%
|
-20.40
-59.21%
|
-12.81
+65.55%
|
-37.20
|
| Common Stock Issuance |
|
1.53
|
0.00
-100.00%
|
60.15
|
0.00
|
| Interest Paid CFF |
|
-1.53
-56.12%
|
-0.98
+85.96%
|
-6.98
-662.62%
|
-0.92
|
| Issuance Of Capital Stock |
|
1.53
|
0.00
-100.00%
|
60.15
|
0.00
|
| Taxes Refund Paid |
|
-0.20
-219.35%
|
-0.06
-785.71%
|
-0.01
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|